Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial

Table 3

Changes in uterine volumes (c.c.) by treatment groups and evaluation periods.

Evaluation at	Group	𝑛	Mean ± S.D.	95% CI for mean	Changes (%)	𝑃^∗
Before treatment	2.5 mg	110	455 ± 314	372–492	—	.486
	5 mg	110	426 ± 305	347–467
3-month treatment	2.5 mg	102	372 ± 272	324–433	18.2 ↓	.264
	5 mg	106	332 ± 243	282–378	22.1 ↓
3-month followup	2.5 mg	98	418 ± 266	368–490	8.1 ↓	.349
	5 mg	104	379 ± 320	300–395	11.0 ↓
6-month followup	2.5 mg	93	437 ± 274	386–510	4.0 ↓	.279
	5 mg	103	478 ± 255	291–670	12.2 ↑
9-month followup	2.5 mg	90	495 ± 321	429–569	8.8 ↑	.888
	5 mg	100	489 ± 265	309–421	14.8 ↑

^∗𝑡-test (ANOVA); CI: confidence interval; SD: standard deviation.